Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
American Academy of Neurology 55th Annual Meeting
March 29, 2003 - April 5, 2003, Honolulu, Hawaii

Authors: Stephen D. Silberstein, MD,FACP; Rohit Bakshi, MD; Robert C. Green, MD, MPH

This activity is not sanctioned by, nor a part of, the American Academy of Neurology.


Medscape Editorial Note, February 9, 2005

Since the writing of this content, certain published data analyses and public announcements have called into question the cardiovascular safety of some of the COX-2 inhibitors and standard NSAIDs. Results of such publications may have affected certain information contained in this article, causing it to be outdated or possibly inaccurate. In order to keep our members current on this important therapeutic area, Medscape is providing regularly updated information related to NSAIDs in the Medscape NSAID Alert Center. This center includes commentary, abstracts, and statements from the US Food and Drug Administration, National Institutes of Health, and other policy makers, as well as other articles that are intended to provide supplementary information for assessing the accuracy of this content.


Contents
Headache Treatments and Prophylaxis Also Elucidate Pathophysiology
Stephen D. Silberstein, MD, FACP
Illuminating the Brain: Neuroimaging Highlights
Rohit Bakshi, MD
Advances in Understanding Dementia and Its Management
Robert C. Green, MD, MPH
In Search of Better Therapies for MS
Rohit Bakshi, MD
Related Article
Movement Disorder Highlights from WE MOVE

 
Conference News
Botulinum Toxin A Safe for Cerebral Palsy 4/7/03
[Medscape Medical News]
Longest retrospective study finds treatment to be safe and improvements were sustained.
First Cholinesterase Inhibitor for Mild Cognitive Impairment 4/7/03
[Medscape Medical News]
Most of the donepezil results were modest, but they reached significance on memory tests.
West Nile Virus Can Mimic Other Neurologic Diseases 4/4/03
[Medscape Medical News]
West Nile virus can present with focal neurologic deficits or symptoms similar to Parkinson's disease, polio, and Guillain-Barre syndrome.
Anti-epileptic Reduces Migraines, Weight 4/4/03
[Medscape Medical News]
Largest migraine prevention trial finds that topiramate is safe and effective.
Voluntary Reporting of Epilepsy Seizures Recommended 4/3/03
[Medscape Medical News]
Mandatory reporting leads patients to withhold information, according to a survey presented at the American Academy of Neurology meeting.
Early Use of Campath in MS May Decrease Disability 4/3/03
[Medscape Medical News]
But nearly 30% of those treated developed autoimmune thyroid disease, which resolved with early treatment.
Capsaicin Patch Eases Postherpetic Neuralgia Pain 4/3/03
[Medscape Medical News]
A one-hour application reduced the pain by 33% for up to one month, according to a presentation at the American Academy of Neurology 55th annual meeting.
Levodopa Does Not Hasten Clinical Parkinson's Progression 4/2/03
[Medscape Medical News]
But a neuroimaging study showed levodopa caused a more rapid decline in the integrity of the dopamine transporter.
Statin Appears Promising for MS 4/2/03
[Medscape Medical News]
Simvastatin was observed to be safe and reduced lesions in an open-label study.
More Evidence That NSAIDs Reduce Alzheimer's Risk 4/1/03
[Medscape Medical News]
This meta-analysis presented at the American Academy of Neurology 55th annual meeting suggests greatest effect after 2 years of use.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the American Academy of Neurology. These materials and the related activity are not sanctioned by the American Academy of Neurology or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing medical education activity.
Copyright © 2003 Medscape.

 
WebMD
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.